Celanese Corporation

CE

US1508701034

Specialty Chemicals

Market Closed - Nyse Other stock markets 04:00:02 2024-04-24 pm EDT			5-day change	1st Jan Change
155.4 ^USD	-0.40%		+0.61%	+0.04%

Apr. 22	Celanese Corporation Announces Directorate Changes	CI
Apr. 19	RBC Raises Price Target on Celanese to $171 From $165, Keeps Outperform Rating	MT

Tranche Update on Celanese Corporation (NYSE:CE)'s Equity Buyback Plan announced on April 18, 2019.

October 21, 2021 at 04:23 pm EDT

From July 1, 2021 to September 30, 2021, the company has repurchased 1,938,179 shares, representing 1.74% for $300.01 million. With this, the company has completed the repurchase of 13,559,179 shares, representing 11.64% for $1,737.24 million under the buyback announced on April 18, 2019.

Latest news about Celanese Corporation

Celanese Corporation Announces Directorate Changes	Apr. 22	CI
RBC Raises Price Target on Celanese to $171 From $165, Keeps Outperform Rating	Apr. 19	MT
Celanese Keeps Quarterly Dividend at $0.70 a Share, Payable May 13 to Stockholders of Record April 29	Apr. 17	MT
Celanese Corporation Declares Quarterly Dividend, Payable on May 13, 2024	Apr. 17	CI
BofA Securities Raises Price Target on Celanese to $145 From $135, Maintains Underperform Rating	Apr. 10	MT
KeyBanc Raises Price Target on Celanese to $190 From $176, Keeps Overweight Rating	Apr. 09	MT
UBS Raises Celanese's Price Target to $199 From $175, Maintains Buy Rating	Apr. 08	MT
North American Morning Briefing : Investors on -2-	Apr. 05	DJ
JPMorgan Downgrades Celanese to Underweight From Neutral, Raises Price Target to $160 From $135	Apr. 04	MT
ANALYST RECOMMENDATIONS : Block, Chubb, Doordash, Coinbase, Lloyds...	Apr. 04
Wells Fargo Raises Price Target on Celanese to $195 From $180, Maintains Overweight Rating	Mar. 22	MT
Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense Therapies	Mar. 20	CI
William M. Brown Announces Not Stand for Re-Election to the Board of Celanese Corporation	Mar. 14	CI
Just as expected	Feb. 29
ANALYST RECOMMENDATIONS : Amex, Snowflake, Salesforce, Walmart, Nutrien...	Feb. 29
Celanese Corporation Elects Timothy Go to Board of Directors	Feb. 28	CI
North American Morning Briefing : Stock Futures -2-	Feb. 27	DJ
Celanese Earnings Likely to Improve in 2024 Despite Demand Headwinds, RBC Says	Feb. 26	MT
Deutsche Bank Adjusts Celanese Price Target to $160 From $125, Maintains Hold Rating	Feb. 26	MT
How long will this bullish phase last?	Feb. 26
Piper Sandler Upgrades Celanese to Overweight From Neutral, Raises Price Target to $170 From $135	Feb. 26	MT
RBC Trims Price Target on Celanese to $165 From $168, Notes 'Demand Headwinds' Likely to Persist Into Q1, Keeps Outperform Rating	Feb. 26	MT
ANALYST RECOMMENDATIONS : AbbVie, Doordash, Eli Lilly, Moderna, Hiscox...	Feb. 26
Baird Adjusts Celanese's Price Target to $165 From $135, Keeps Outperform Rating	Feb. 22	MT
JPMorgan Adjusts Celanese's Price Target to $135 From $125, Keeps Neutral Rating	Feb. 22	MT

Chart Celanese Corporation

Duration

Period

More charts

Company Profile

Celanese Corporation specializes in the manufacture and marketing of chemicals and specialty materials. The products are intended for the production of automotive components, beverages and food products, cigarette filters, paints and coatings, packaging, textiles, etc. Net sales by category of products break down as follows: - acetyl products (55.7%); - high performance engineering polymers (44.3%). Net sales are distributed geographically as follows: the United States (25.8%), Germany (22.6%), China (17.8%), Singapore (10.5%), Belgium (4.6%), Mexico (3.3%), Japan (2.9%), Switzerland (2%), India (1.4%), South Korea (1.4%), Brazil (1.3%), Canada (1.3%), France ( 0.8%), the United Kingdom (0.8%), Italy (0.7%), Spain (0.5%), and other (2.3%).

Sector

Specialty Chemicals

Calendar

2024-05-07 - Q1 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Celanese Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

155.4 USD

Average target price

162 USD

Spread / Average Target

+4.23%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

	1st Jan change	Capi.
CELANESE CORPORATION	+0.04%	17.34B
ECOLAB INC.	+11.31%	63.12B
SIKA AG	-5.19%	45.55B
GIVAUDAN SA	+15.01%	40.45B
FUJIFILM HOLDINGS CORPORATION	+17.51%	26.45B
EMS-CHEMIE HOLDING AG	+5.07%	18.31B
SYMRISE AG	+4.48%	15.55B
POSCO FUTURE M CO., LTD.	-17.27%	16.71B
ALBEMARLE CORPORATION	-20.22%	13.55B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-28.15%	12.36B

Other Specialty Chemicals

Celanese Corporation

Equities

CE

US1508701034

Specialty Chemicals

Tranche Update on Celanese Corporation (NYSE:CE)'s Equity Buyback Plan announced on April 18, 2019.

EPS Revisions